Literature DB >> 12139551

Cardiac arrest after intravenous metoclopramide - a case of five repeated injections of metoclopramide causing five episodes of cardiac arrest.

G Bentsen1, A Stubhaug.   

Abstract

We describe a patient where intravenous injection of metoclopramide was immediately followed by asystole repeatedly. The patient received metoclopramide 10 mg i.v. five times during 48 h. After interviewing the attending nurses and reviewing the written documentation, it is clear that every administration of metoclopramide was immediately (within s) followed by asystole. The asystole lasted 15-30 s on four occasions, on one occasion it lasted 2 min. The patient received atropine 0.5-1 mg and chest compressions, before sinus rhythm again took over. We interpret this as episodes of cardiac arrest caused by metoclopramide. The rapid injection via the central venous route and the concomitant tapering of dopamine infusion might have contributed in precipitating the adverse drug reaction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12139551     DOI: 10.1034/j.1399-6576.2002.460725.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  5 in total

1.  Cisapride and ventricular arrhythmia.

Authors:  Sean Hennessy; Charles E Leonard; Craig Newcomb; Stephen E Kimmel; Warren B Bilker
Journal:  Br J Clin Pharmacol       Date:  2008-07-23       Impact factor: 4.335

2.  Idiopathic and Diabetic Gastroparesis.

Authors:  Deirdre O'Donovan; Christine Feinle-Bisset; Karen Jones; Michael Horowitz
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08

3.  Metoclopramide-induced cardiac arrest.

Authors:  Martha M Rumore; Spencer Evan Lee; Steven Wang; Brenna Farmer
Journal:  Clin Pract       Date:  2011-11-02

4.  Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study.

Authors:  Alejandro Arana; Catherine B Johannes; Lisa J McQuay; Cristina Varas-Lorenzo; Daniel Fife; Kenneth J Rothman
Journal:  Drug Saf       Date:  2015-12       Impact factor: 5.606

5.  Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study.

Authors:  Qasim Khan; Mohammad Ismail; Sehrash Khan
Journal:  BMC Pharmacol Toxicol       Date:  2017-12-01       Impact factor: 2.483

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.